PNVL3 logo

Dimed S.A. Distribuidora de Medicamentos Stock Price

BOVESPA:PNVL3 Community·R$1.7b Market Cap
  • 1 Narratives written by author
  • 0 Comments on narratives written by author
  • 15 Fair Values set on narratives written by author
Author Program NEWCreate Narrative

PNVL3 Share Price Performance

R$11.26
2.05 (22.26%)
​
R$17.60
Fair Value
R$11.26
2.05 (22.26%)
36.0% undervalued intrinsic discount
R$17.60
Fair Value
Price R$11.26
AnalystConsensusTarget R$17.60

PNVL3 Community Narratives

Fair Value
·
Fair Value R$17.6 36.0% undervalued intrinsic discount

Digital Strategy And AI Investments Will Improve Efficiency In Pharma Retail

0users have liked this narrative
0users have commented on this narrative
11users have followed this narrative
PNVL3 logo
Dimed Distribuidora de Medicamentos

Digital Strategy And AI Investments Will Improve Efficiency In Pharma Retail

A Brazilian pharmacy retailer is leaning hard into online shopping, loyalty programs, and smarter store tech to sell more while running a tighter operation. But big bets on expansion and a past hit from severe flooding show why the growth story could still get knocked off course.Read more

View narrative
R$17.6
36.0% undervalued intrinsic discount
Fair Value
Revenue
13.85% p.a.
Profit Margin
3.43%
Future PE
15.49x
Price in 2029
R$30.11

Trending Discussion

No trending discussion available.

Updated Narratives

PNVL3 logo

PNVL3: 2026 Extraordinary Meetings Will Support Bullish Repricing Case

Fair Value: R$17.6 36.0% undervalued intrinsic discount
11 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Solid track record with reasonable growth potential.

0 Risks
4 Rewards
View Full Analysis

Dimed S.A. Distribuidora de Medicamentos Key Details

R$5.7b

Revenue

R$3.7b

Cost of Revenue

R$2.0b

Gross Profit

R$1.8b

Other Expenses

R$132.4m

Earnings

Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
n/a
0.89
34.56%
2.32%
46.2%
View Full Analysis

About PNVL3

Founded
1920
Employees
11282
CEO
Julio Mottin Neto
WebsiteView website
www.grupopanvel.com.br

Dimed S.A. Distribuidora de Medicamentos sells medicines, perfumeries, personal hygiene and beauty products, cosmetics and dermocosmetics in Brazil. It sells its products through physical stores in retail industry. Dimed S.A. Distribuidora de Medicamentos was founded in 1920 and is headquartered in Eldorado do Sul, Brazil.

Recent PNVL3 News & Updates

Narrative Update • Jun 19

PNVL3: 2026 Extraordinary Meetings Will Support Bullish Repricing Case

Analysts have trimmed their price target on Dimed Distribuidora de Medicamentos stock from R$18.60 to R$17.60, citing updated assumptions that combine slightly higher projected revenue growth with modestly lower profit margins and a somewhat reduced future P/E multiple. What’s in the News for Dimed Distribuidora de Medicamentos A special and extraordinary shareholders meeting is scheduled for April 30, 2026, at Avenida Industrial Belgraf 865, Eldorado do Sul, Rio Grande do Sul, Brazil, according to key developments data.
Narrative Update • Jun 04

PNVL3: 2026 Shareholder Meetings Will Support Confident Repricing Case

Analysts have trimmed their price target on Dimed Distribuidora de Medicamentos slightly from R$18.80 to R$18.60, reflecting updated assumptions around discount rates, revenue growth, profit margins and future P/E levels. What's in the News Dimed Distribuidora de Medicamentos has scheduled a Special and Extraordinary Shareholders Meeting for April 30, 2026, at Avenida Industrial Belgraf 865, Eldorado do Sul, Rio Grande do Sul, Brazil.

Recent updates

No updates

Dimed S.A. Distribuidora de Medicamentos Competitors

RADL3 logo

Raia Drogasil

Symbol: BOVESPA:RADL3
Market cap: R$31.7b
ASAI3 logo

Sendas Distribuidora

Symbol: BOVESPA:ASAI3
Market cap: R$11.1b
GMAT3 logo

Grupo Mateus

Symbol: BOVESPA:GMAT3
Market cap: R$8.8b
PGMN3 logo

Empreendimentos Pague Menos

Symbol: BOVESPA:PGMN3
Market cap: R$2.5b
View more competitors